我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

药物基因组学研究与高血压病的个体化用药

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第3期
页码:
441-443
栏目:
综述
出版日期:
2010-04-06

文章信息/Info

Title:
-
作者:
徐承华; 杨玉雯
皖南医学院弋矶山医院，安徽 芜湖 241001
Author(s):
-
关键词:
高血压; 个体化治疗; 药物基因组学
Keywords:
-
分类号:
R544.1
DOI:
-
文献标识码:
A
摘要:
药物基因组学是高血压病个体化治疗的分子生物学基础。高血压病药物基因组学的深入研究，为临床医生选择更适合个体的抗高血压治疗提供依据，从而达到最有利于患者的治疗效果。
Abstract:
-

参考文献/References

［1］ Schelleman H, Klungel OH, van Duijn CM, et al. Drug gene interaction between the insertion/deletion polymorphism of the angiotensin converting enzyme gene and antihypertensive therapy［J］. The Annals of Pharmacot herapy, 2006, 40(2):212-218.

［2］ Turner ST, Schwartz GL. Gene markers and antihypertensive therapy［J］. Current Hypertension Rreports, 2005, 7(1):21-30.

［3］ Sadee W, Dai Z. Pharmacogenetics/genomics and personalize medicine［J］. Hum Mol Genet, 2005, 14(2):207-214.

［4］Romkes M, Buch SC. Genetyping technologies: application to biotrans formation enzyme genetic polymorphism screening Methods［J］. Mol Biol, 2005, 291:399-414.

［5］Manunta P, Bianchi G. Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives-the adducin paradigm［J］. J Am Soc Nephrol, 2006, 17(4 Suppl 2):S30-S35.

［6］Schelleman H, Stricker BHC, Boer AD, et al. Drug Gene Interactions between Genetic Polymorphisms and Antihypertensive Therapy［J］. Drugs, 2004, 64(16):1801-1816.

［7］ Arnett DK, Claas SA, Glasser SP. Pharmacogenetics of antihypertensive treatment［J］. Vascular Pharmacology, 2006, 44(2):107-118.

［8］Schelleman H, Stricker BH, Boer AD, et al. Drug gene interactions between genetic polymorphisms and antihypertensive theray［J］. Drugs, 2004, 64(16):1801-1816.

［9］Psaly BM, Smith NL, Heckbert SR, et al. Diuretic therapy, theα-adduein gene variant and the risk of myocardial infarction or stroke in persons with treated hypertension［J］. JAMA, 2002, 287(13):1680-l689.

［10］Minushkina LO, Zateishchikov DA, Sidorenko BA. Individual sensitivity to antihypertensive drugs: genetic aspects［J］. Kardiologiia, 2005, 45(7):58-65.

［11］Liu J, Liu ZQ, Tan ZR, et al. Gly389Arg polymorphism of beta1 adrenergic receptor is associated with the cardiovascular response to metoprolol［J］. Clin Pharmacol Ther, 2003, 74(4):372-379.

［12］Kurland L, Liljedahl U, Karlsson J, et al. Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol( SILVHIA)trial［J］. Am J Hypertens, 2004, 17(1):8-13.

［13］Felix CA, Walker AH, Lane BJ, et al. Association of CYP3A4 genotype with treatment-related leukemia［J］. Proc Nagl Acad Sci USA, 1998, 95(22):13176-13181.

［14］Trotta R, Donati MB, Iacoviello L. Trends in pharmacogenomics of drugs acting on hypertension［J］ . Pharmacological Research , 2004, 49(4):351-356.

［15］Beeks E, Kessels AG, Kroon AA, et al. Genetic predisposition to salt-sensitivity: a systematic review［J］. J Hypertens, 2004, 22(7):1243-1249.

[16]Walter F. Challenge of personalized health care to what extenis medicine already individualized and what are the future trend［J］. Med Sci Monit, 2004, 10(5):111-123.

[17]Johnson JA, Turner ST. Hypertension pharmacogenomics current status and future directions［J］. Curr Opin Mol Ther, 2005, 7(3):218-225.

［18］anneito PJ, Laleli-Sahin E, Wong SH. Pharmacogenomic genotyping methodologies［J］. Clin Chem Lab Med, 2004, 42(11):1256-1264.

备注/Memo

备注/Memo:
收稿日期：2009-06-10.通讯作者：杨玉雯，主任医师，主要从事高血压病基因组学研究Email:YANGYUWENWH@Yahoo.com.cn 作者简介：徐承华，主治医师，硕士生 Email:xuchenghua88@sina.com
更新日期/Last Update: 2010-04-09